Testing effectiveness (Phase 2)Not Yet RecruitingNCT07839936
What this trial is testing
VERVE-102 (LY4636581) in Adults With or at High Risk for Cardiovascular Disease
Who this might be right for
AtherosclerosisCardiovascular DiseaseHypercholesterolemia
Verve Therapeutics, Inc. 175